Pfizer strikes $150M deal for oral GLP-1

YaoPharma's once-daily oral GLP-1 drug is currently in Phase 1 testing. The license agreement gives Pfizer global rights to the small molecule, which it envisions as part of potential drug combinations.

Editor's Pick

Top Story Pfizer's Appetite for More Obesity Meds Leads to $150M Deal for Oral GLP-1 Drug From China YaoPharma's once-daily oral GLP-1 drug is currently in Phase 1 testing. The license agreement gives Pfizer global rights to the small molecule, which it envisions as part of potential drug combinations. Sponsored Helping to Transform Healthcare with Transparent Data Insights Presented by Claritev Claritev helps make healthcare clearer, smarter, and more affordable. With 40+ years of claims repricing expertise and powerful AI technology, we turn complex data into actionable insights. Our enterprise platform drives price transparency, optimizes networks, and reshapes benefit plan design—helping payers, providers, and employers deliver real value in healthcare.  Learn more

Featured News

Mark Cuban: Employers Are Unknowingly Profiting From Sick Workers' Drug Costs Mark Cuban warned that many employers are collecting drug rebate money funded by their sick employees — a practice that can violate fiduciary duties under ERISA. His company, Cost Plus Drugs, is partnering with organizations like Humana's CenterWell to create direct-to-employer programs that bypass PBMs and deliver medications at lower net prices. Zocdoc Partners with Healthgrades to Help People Book Doctor's Appointments Through a partnership with Zocdoc, patients will be able to find providers who accept their insurance, view real-time availability for appointments and book appointments directly through the Healthgrades website. Comorbidities Are Driving Up Healthcare Costs — Here's How More Specialized Care Management Can Bring Them Under Control To bend the cost curve, we need a smarter, more integrated approach to care management — one capable of addressing rising upstream cost drivers, while still delivering high-quality, patient-centered outcomes.  If People Can Use TikTok, Why Can't They Use Healthcare? Healthcare's next frontier isn't policy reform or payment reform. It's experience reform — reimagining every touchpoint between members, providers, and plans through the lens of design and empathy.

Video   What Are Investors Looking For In Mental Health Startups? At a recent behavioral health tech conference, Emily Durfee, a partner at Healthworx Ventures, shared her thoughts on how to differentiate mental health startups in an increasingly crowded market. She said it's important to figure out if the startup is solving a key problem for their customer — whether that's a provider, payer, employer or consumer.

Sponsored As Healthcare and Biopharma Companies Embrace AI, Insurance Underwriters See Risks and Opportunities Presented by Munich Re Specialty – North America In an interview, Munich Re Specialty Senior Vice President Jim Craig talked about the risk that accompanies innovation and the important role that insurers play. Learn More

Resources

MedCity FemFwd: How Women's Health Advocates Is Pushing for Change In this episode, we're joined by Liz Powell, founder of Women's Health Advocates. We discussed the organization's policy priorities in the women's health space. View Now

MedCity News • PO Box 901 • New York, NY unsubscribe